Login Register Cart 0
Generic placeholder image

Current Proteomics

Editor-in-Chief

ISSN (Print): 1570-1646
ISSN (Online): 1875-6247

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Higher Abundance of Vitronectin (S-protein) in Serum-derived Exosomes of Pulmonary and Extra-Pulmonary Tuberculosis Patients as Compared to HIV-Tuberculosis Dual-infected Patients and Healthy Humans

Author(s): Shweta Kushwaha, Rajbala Yadav, Kusuma Sai Davuluri, Anjana Goel, Devendra Singh Chauhan and Ajay Vir Singh*

Volume 20, Issue 1, 2023

Published on: 26 May, 2023

Page: [75 - 79] Pages: 5

DOI: 10.2174/1570164620666230508140912

Price: $65

Abstract

Background: Despite the crucial involvement of vitronectin in affecting the perseverance of certain respiratory pathogens and the progression of several lung diseases, the association of vitronectin with tuberculosis (TB) has been poorly studied. The present study aimed to determine whether vitronectin levels are altered in TB patients compared to healthy humans.

Methods: Twenty-four laboratory-confirmed tuberculosis patients (pulmonary TB -8, extrapulmonary- 8 and HIV-TB dual infected -8) and eight healthy individuals were included in this study. The quantitative detection of vitronectin in serum-derived exosomes of study participants was performed using a sandwich enzyme-linked immunosorbent assay. Measured concentrations of vitronectin were compared with the demographic variables of the study participants and between the study groups. The Mann–Whitney U unpaired test was used in statistical analysis, and the p-value < 0.05 was considered statistically significant.

Results: Vitronectin was detected in serum-derived exosomes of all study participants. The demographic characteristics (gender, age, smoking and alcohol consumption habit, history of cough, and weight loss) were not significantly correlated with the vitronectin concentrations of the study participants (p-value> 0.05). The level of vitronectin was higher in patients with pulmonary TB (778.54 ng/l) and extra-pulmonary-TB patients (773.04 ng/l) while lower in HIV-pulmonary TB dual-infected patients (354.86 ng/l) as compared to healthy humans (456.20ng/l). There was a significant difference between vitronectin concentrations of patients with pulmonary TB (p-value: 0.0002) and extrapulmonary TB (p-value: 0.003) compared to healthy controls.

Conclusion: The present study reported an increased concentration of vitronectin in serum-derived exosomes of pulmonary and extra-pulmonary TB patients compared to HIV-TB dual-infected patients and healthy humans. Further studies are needed to fully elucidate the diagnostic potential and functionalities of higher concentrations of vitronectin in the pathogenic processes of human TB.

Keywords: Vitronectin, pulmonary tuberculosis, HIV-TB co-infection, extra-pulmonary tuberculosis, ELISA, respiratory disease.

« Previous Next »
Graphical Abstract

[1]
Singh, B.; Su, Y.C.; Riesbeck, K. Vitronectin in bacterial pathogenesis: A host protein used in complement escape and cellular invasion. Mol. Microbiol., 2010, 78(3), 545-560.
[http://dx.doi.org/10.1111/j.1365-2958.2010.07373.x] [PMID: 20807208]
[2]
Tegla, C.A.; Cudrici, C.; Patel, S.; Trippe, R., III; Rus, V.; Niculescu, F.; Rus, H. Membrane attack by complement: The assembly and biology of terminal complement complexes. Immunol. Res., 2011, 51(1), 45-60.
[http://dx.doi.org/10.1007/s12026-011-8239-5] [PMID: 21850539]
[3]
Hallström, T.; Blom, A.M.; Zipfel, P.F.; Riesbeck, K. Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J. Immunol., 2009, 183(4), 2593-2601.
[http://dx.doi.org/10.4049/jimmunol.0803226] [PMID: 19635912]
[4]
Limper, A.H.; Standing, J.E.; Hoffman, O.A.; Castro, M.; Neese, L.W. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun., 1993, 61(10), 4302-4309.
[http://dx.doi.org/10.1128/iai.61.10.4302-4309.1993] [PMID: 7691747]
[5]
Bergmann, S.; Lang, A.; Rohde, M.; Agarwal, V.; Rennemeier, C.; Grashoff, C.; Preissner, K.T.; Hammerschmidt, S. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J. Cell Sci., 2009, 122(2), 256-267.
[http://dx.doi.org/10.1242/jcs.035600] [PMID: 19118218]
[6]
Paulsson, M.; Liang, O.D.; Ascencio, F.; Wadström, T. Vitronectin-binding surface proteins of Staphylococcus aureus. Zentralbl. Bakteriol., 1992, 277(1), 54-64.
[http://dx.doi.org/10.1016/S0934-8840(11)80871-6] [PMID: 1381645]
[7]
Chhatwal, G.S.; Preissner, K.T.; Müller-Berghaus, G.; Blobel, H. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Infect. Immun., 1987, 55(8), 1878-1883.
[http://dx.doi.org/10.1128/iai.55.8.1878-1883.1987] [PMID: 2440809]
[8]
Limper, A.H.; Standing, J.E. Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol. Lett., 1994, 42(3), 139-144.
[http://dx.doi.org/10.1016/0165-2478(94)90077-9] [PMID: 7534269]
[9]
Paulsson, M.; Che, K.F.; Ahl, J.; Tham, J.; Sandblad, L.; Smith, M.E.; Qvarfordt, I.; Su, Y.C.; Lindén, A.; Riesbeck, K. Bacterial outer membrane vesicles induce vitronectin release into the bronchoalveolar space conferring protection from complement-mediated killing. Front. Microbiol., 2018, 9(9), 1559.
[http://dx.doi.org/10.3389/fmicb.2018.01559] [PMID: 30061873]
[10]
Tan, Y.H.; Gamage, A.M.; Gan, Y.H. Complement-activated vitronectin enhances the invasion of nonphagocytic cells by bacterial pathogens Burkholderia and Klebsiella. Cell. Microbiol., 2017, 19(8), e12732.
[http://dx.doi.org/10.1111/cmi.12732] [PMID: 28186697]
[11]
De Gaetano, G.V.; Pietrocola, G.; Romeo, L.; Galbo, R.; Lentini, G.; Giardina, M.; Biondo, C.; Midiri, A.; Mancuso, G.; Venza, M.; Venza, I.; Firon, A.; Trieu-Cuot, P.; Teti, G.; Speziale, P.; Beninati, C. The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/α v integrin axis. Mol. Microbiol., 2018, 110(1), 82-94.
[http://dx.doi.org/10.1111/mmi.14084] [PMID: 30030946]
[12]
Wu, Y.; Deng, W.; Klinke, D.J. II Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst, 2015, 140(19), 6631-6642.
[http://dx.doi.org/10.1039/C5AN00688K] [PMID: 26332016]
[13]
Kemkes-Matthes, B.; Preissner, K.T.; Langenscheidt, F.; Matthes, K.J.; Müller-Berghaus, G. S protein/vitronectin in chronic liver diseases: Correlations with serum cholinesterase, coagulation factor X and complement component C3. Eur. J. Haematol., 1987, 39(2), 161-165.
[http://dx.doi.org/10.1111/j.1600-0609.1987.tb00747.x] [PMID: 2444458]
[14]
Preissner, K.T.; Seiffert, D. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb. Res., 1998, 89(1), 1-21.
[http://dx.doi.org/10.1016/S0049-3848(97)00298-3] [PMID: 9610756]
[15]
Hetland, G.; Pettersen, H.B.; Mollnes, T.E.; Johnson, E. S-protein is synthesized by human monocytes and macrophages in vitro. Scand. J. Immunol., 1989, 29(1), 15-21.
[http://dx.doi.org/10.1111/j.1365-3083.1989.tb01094.x] [PMID: 2466326]
[16]
Preissner, K.T.; Holzhuter, S.; Muller-Berghaus, G. Identification and partial characterization of platelet Sprotein. Haemostasis, 1988, 18, 149.
[17]
Kanz, L.; Lohr, G.W.; Preissner, K.T. Identification of human megakaryocyte vitronectin/S-protein. Blood, 1988, 72, 372a.
[18]
Pohl, W.R.; Conlan, M.G.; Thompson, A.B.; Ertl, R.F.; Romberger, D.J.; Mosher, D.F.; Rennard, S.I. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am. Rev. Respir. Dis., 1991, 143(6), 1369-1375.
[http://dx.doi.org/10.1164/ajrccm/143.6.1369] [PMID: 1710880]
[19]
Lundberg, F.; Schliamser, S.; Ljungh, A. Vitronectin may mediate staphylococcal adhesion to polymer surfaces in perfusing human cerebrospinal fluid. J. Med. Microbiol., 1997, 46(4), 285-296.
[http://dx.doi.org/10.1099/00222615-46-4-285] [PMID: 9128192]
[20]
Schneider, G.; Suszynska, M.; Kakar, S.; Ratajczak, M.Z. Vitronectin in the ascites of human ovarian carcinoma acts as a potent chemoattractant for ovarian carcinoma: Implication for metastasis by cancer stem cells. J. Cancer Stem Cell Res., 2016, 4(5), 1.
[http://dx.doi.org/10.14343/JCSCR.2016.4e1005] [PMID: 28603747]
[21]
Caby, M.P.; Lankar, D.; Vincendeau-Scherrer, C.; Raposo, G.; Bonnerot, C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol., 2005, 17(7), 879-887.
[http://dx.doi.org/10.1093/intimm/dxh267] [PMID: 15908444]
[22]
Pisitkun, T.; Shen, R.F.; Knepper, M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA, 2004, 101(36), 13368-13373.
[http://dx.doi.org/10.1073/pnas.0403453101] [PMID: 15326289]
[23]
Singh, B.; Janardhan, K.S.; Kanthan, R. Expression of angiostatin, integrin α v β 3, and vitronectin in human lungs in sepsis. Exp. Lung Res., 2005, 31(8), 771-782.
[http://dx.doi.org/10.1080/01902140500324901] [PMID: 16368651]
[24]
Paulsson, M.; Che, K.F.; Ahl, J.; Smith, M.E.; Qvarfordt, I.; Su, Y-C.; Linden, A.; Riesbeck, K. Vitronectin is produced in the lung upon infection by respiratory pathogens, and is utilized to evade the innate immunity. 2017. Available From: https://microbiologysociety.org/event/society-events-and-meetings/focused-meeting-2017-16th-international-conference-on-pseudomonas
[25]
Rodrígues-Cuartero, A.; Nuñez-Carril, J.; Salas-Galán, A.; Rodríguez-Rodríguez, M.A. Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis. Infection, 1993, 21(5), 303-305.
[http://dx.doi.org/10.1007/BF01712450] [PMID: 8300246]
[26]
Boyd, N.A.; Bradwell, A.R.; Thompson, R.A. Quantitation of vitronectin in serum: Evaluation of its usefulness in routine clinical practice. J. Clin. Pathol., 1993, 46(11), 1042-1045.
[http://dx.doi.org/10.1136/jcp.46.11.1042] [PMID: 7504702]
[27]
Lepedda, A.J.; Deiana, G.A.; Lobina, O.; Nieddu, G.; Baldinu, P.; De Muro, P.; Andreetta, F.; Sechi, E.; Arru, G.; Corda, D.G.; Sechi, G.P.; Formato, M. Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential. J. Circ. Biomark., 2019, 8.
[http://dx.doi.org/10.1177/1849454419875912] [PMID: 31588250]
[28]
Salazar-Peláez, L.M.; Abraham, T.; Herrera, A.M.; Correa, M.A.; Ortega, J.E.; Paré, P.D.; Seow, C.Y. Vitronectin expression in the airways of subjects with asthma and chronic obstructive pulmonary disease. PLoS One, 2015, 10(3), e0119717.
[http://dx.doi.org/10.1371/journal.pone.0119717] [PMID: 25768308]

Rights & Permissions Print Cite
Article Metrics
19
3
© 2024 Bentham Science Publishers | Privacy Policy